Human Envelop VLP Control, Accession:

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Human Envelop VLP Control is expressed from HEK293. Human Envelop VLP Control is formed by self-assembly of envelop/capsid proteins from viruses, which is pure viral protein particle structure without the displayed proteins. Human Envelop VLP Control can be used as isoytype control for VLPs displaying membrane proteins in various applications.

    Biotinylated

    产物规格

    靶点

    Envelop VLP Control

    份子又名

    Gag polyprotein; Pr55Gag; MA; CA; SP1; p2; nc; SP2; p1; p6-gag

    Accession

    种属

    Human

    卵白序列

    份子量

    活性

    产物标签

    抒发体系

    HEK293

    纯度

    > 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该乙酰乙酸的加盟品牌ChemWhat是Watson的注册公司钢号，由Watson受权杭州海角社区 在华人内地城市借助，.